Journal article
Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare
Journal of Clinical Microbiology, Vol.52(2), pp.650-653
2014
Abstract
The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Details
- Title
- Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare
- Authors
- Derek S Sarovich (Author) - Menzies School of Health ResearchL Ward (Author) - Menzies School of Health ResearchErin P Price (Author) - Menzies School of Health ResearchM Mayo (Author) - Menzies School of Health ResearchM C Pitman (Author) - Royal Darwin HospitalR W Baird (Author) - Royal Darwin HospitalB J Currie (Author) - Menzies School of Health Research
- Publication details
- Journal of Clinical Microbiology, Vol.52(2), pp.650-653
- Publisher
- American Society for Microbiology
- Date published
- 2014
- DOI
- 10.1128/JCM.02239-13
- ISSN
- 0095-1137
- Copyright note
- Copyright © 2014 American Society for Microbiology. Reproduced here in accordance with the publisher's copyright policy.
- Organisation Unit
- University of the Sunshine Coast, Queensland; Centre for Bioinnovation
- Language
- English
- Record Identifier
- 99450567302621
- Output Type
- Journal article
Metrics
40 File views/ downloads
246 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Web Of Science research areas
- Microbiology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites